Document is current
Any future updates will be listed below
-
Authors
Lei, Chuqi
Lu, Wei
Li, Yuan
yang, Huaiyu
Zhang, Ke
Wang, Nianchang
Xuan, Lixue
Guo, Changyuan
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82372078, 82372078, 82372078, 82372078, 82372078, 82372078, 82372078, 82372078)
Beijing Xisike Clinical Oncology Research Foundation (Y-NESTLE2022MS-0036, Y-NESTLE2022MS-0036, Y-NESTLE2022MS-0036, Y-NESTLE2022MS-0036, Y-NESTLE2022MS-0036, Y-NESTLE2022MS-0036, Y-NESTLE2022MS-0036, Y-NESTLE2022MS-0036)
- License Information
-
More Information
Article History
Received: 29 March 2025
Accepted: 30 September 2025
First Online: 6 November 2025
Declarations
:
: The authors declare no competing interests.
: All clinical samples were collected from the Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. Written informed consent was obtained from all participants enrolled in this study, and ethical approval was obtained from the following institutional review boards in accordance with the Declaration of Helsinki: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. Approval number: NCC2023C-479. Issued date: 2023-07-18.
: All authors approved the final manuscript and the submission to this journal.
